Dialysis patients may get safer caps to fight deadly infections
NCT ID NCT07019610
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether using a cap containing chlorhexidine on dialysis catheters can reduce infections compared to standard caps. Sixty adults with kidney failure who need dialysis through a central line will be randomly assigned to one of the two caps. The main goal is to see if the study is feasible, not yet to prove the cap works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chlorhexidine
- What this could lead to
- If successful, this could lead to a simple way to reduce serious bloodstream infections in people on dialysis.
- What could go wrong
- This is a very small pilot study (60 people) testing feasibility, not yet effectiveness. The results may not apply to all dialysis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATHETER COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- Aging kidneys under the microscope: could a simple test predict failure?
- Can dialysis change how a kidney drug works? a trial investigates
- Which vein is safer for chemotherapy ports? a trial aims to settle the debate
- Dialysis patients may straighten up with In-Chair exercise
- Virtual nature escape could calm dialysis patients